AI Healthcare Analytics Specialist Interview Questions

A strong answer covers standardization of heterogeneous EHR data into a common schema, enabling multi-site studies and reproducible analytics (OHDSI network).

ICD-10 = diagnosis codes, CPT = procedure codes, NDC = pharmaceutical product identifiers - each serves a distinct purpose in claims analytics.

Cover Safe Harbor (removing 18 identifiers) and Expert Determination (statistical certification). Mention minimum necessary principle.

Structured: lab values, diagnosis codes, vitals in EHR tables. Unstructured: clinical notes, radiology reports, pathology narratives.

Disease prevalence is often low (e.g., 2% sepsis rate), making accuracy misleading. Discuss precision-recall tradeoffs, SMOTE, class weighting, and why calibration matters for clinical utility.

Cover feature selection (demographics, comorbidities, prior utilization, social determinants), cohort definition, handling leakage, model choice (XGBoost, logistic regression), calibration, and deployment considerations.

ClinicalBERT is pre-trained on MIMIC-III clinical notes, capturing medical terminology, abbreviation patterns, and clinical context that general-domain BERT misses.

Cover document ingestion, chunking strategies for medical protocols, embedding generation, vector store setup, retrieval with re-ranking, LLM prompting with grounding, and citation/source attribution.

FHIR (Fast Healthcare Interoperability Resources) provides RESTful APIs and standardized resource definitions (Patient, Encounter, Observation) enabling data exchange across EHR systems.

Discuss MCAR, MAR, MNAR patterns in healthcare. Lab values aren't randomly missing - they're ordered based on clinical suspicion. Cover multiple imputation, complete case analysis pitfalls, and missingness as a feature.

Discuss AUPRC (area under precision-recall curve) for imbalanced data, sensitivity at clinically relevant specificity thresholds, calibration, time-to-detection, alert fatigue, and net benefit (decision curve analysis).

Survival analysis handles censored data (patients lost to follow-up), models time-to-event rather than binary outcomes, and uses Cox regression or Kaplan-Meier methods - critical for oncology and chronic disease analytics.

SDOH (income, housing, food security, education) significantly improve risk models but are often missing, inconsistently coded, or raise privacy/stigma concerns. Discuss Z-codes, Area Deprivation Index, and NLP extraction from notes.

Cohort follows a defined population forward (or retrospectively) to observe outcomes; case-control starts with outcomes and looks backward. Each has different bias profiles and feature engineering implications.

Calibration means predicted probabilities match observed frequencies. A model with great AUC but poor calibration will over/under-estimate risk, leading to wrong clinical decisions. Discuss calibration plots, Hosmer-Lemeshow, Platt scaling.

Define fairness metrics (equalized odds, predictive parity, calibration across groups), identify protected attributes (race, sex, insurance status), measure disparate impact, and discuss tradeoffs - perfect fairness across all metrics is mathematically impossible.

Cover the Total Product Lifecycle (TPLC) approach, predetermined change control plans, Good Machine Learning Practice principles, locked vs. adaptive algorithms, and the difference between clinical decision support (exempt) and diagnostic models (regulated).

Discuss propensity score matching/weighting, inverse probability of treatment weighting (IPTW), target trial emulation framework, handling confounding by indication, and validation against RCT results when available.

Cover assertion classification (present, absent, possible, conditional), temporal reasoning (current vs. historical medications), negation detection (NegEx or transformer-based), medication normalization (RxNorm), and evaluation with i2b2/n2c2 metrics.

Discuss covariate shift detection (PSI, KS tests), concept drift (changing disease presentations), monitoring pipelines, retraining strategies (scheduled vs. triggered), shadow deployment, and the importance of clinical validation before model updates.

Cover federated averaging, differential privacy, secure aggregation, communication efficiency, heterogeneous data distributions (non-IID), and governance - each hospital's IRB, data use agreements, and the role of a trusted coordinator.

Discuss grounding via RAG, chain-of-thought with citations, human-in-the-loop validation, calibration of confidence scores, liability frameworks, and the difference between clinical decision support and autonomous diagnosis.

Cover OMOP-based feature engineering, point-in-time correctness (no future leakage), feature versioning, serving layers (offline batch + online real-time), and governance for reusable clinical features (comorbidity scores, utilization metrics).

Discuss decision curve analysis (net benefit across threshold probabilities), simulation studies, time-motion analyses, clinician trust surveys, prospective silent trials, and the concept of 'clinically meaningful improvement' vs. statistical significance.

Discuss SHAP/LIME for post-hoc explanation, inherently interpretable models (EBM, GAMs), attention visualization for clinical NLP, the regulatory stance on explainability, and when clinician trust requires full transparency vs. validated performance.

Cover handling informative missingness (missingness as a feature), imputation strategy, temporal feature engineering (rolling statistics, rate of change), model selection (LSTM vs. gradient boosting), threshold tuning for alert fatigue management, and prospective validation design.

Cover target trial emulation framework, new-user design, propensity score methods, outcome ascertainment via ICD codes with validation, sensitivity analyses (different definitions, time windows), and regulatory standards (ISPE/ISPOR good practices).

Conduct fairness audit, investigate root causes (data quality, feature representation, label bias), consider model retraining with fairness constraints, evaluate if the performance gap leads to disparate resource allocation, and report findings to clinical leadership with recommendations.

Distinguish between clinical truth vs. billing optimization (upcoding/undercoding), perform error analysis stratified by diagnosis category, evaluate if the NLP model is capturing clinical reality better than billing codes, and clarify the use case requirements.

Discuss few-shot learning approaches, representation learning on patient trajectories (autoencoders, patient2vec), knowledge graph enrichment, handling extreme class imbalance, and clinical expert validation of identified similar patients.

Cover on-premises or private cloud LLM deployment, PHI de-identification before model input (even for internal models), data retention policies, audit logging, BAA requirements with vendors, and a pilot with synthetic data before production rollout.

Discuss tiered alerting (high/medium/low risk), adjusting operating thresholds based on clinical workflow, incorporating alert context (patient trajectory trends, not just point estimates), measuring clinician override rates, and iterative feedback loops.

Discuss external validity (different patient population), reproducibility assessment, prospective validation on local data, operational considerations (inference cost, latency, integration complexity), and the difference between benchmark performance and clinical utility.

Discuss the race correction controversy in eGFR (CKD-EPI 2021 removed race), impact on model features and labels, retraining with race-free equations, communicating the change to clinical users, and the broader context of race as a social vs. biological variable in clinical algorithms.

Cover bias evaluation (ensuring the model doesn't disproportionately flag marginalized communities), avoiding punitive use (flagging for support, not surveillance), transparency to members, clinician override mechanisms, and compliance with 42 CFR Part 2 (substance abuse confidentiality).

Cover PDF parsing (PyPDF, UnstructuredIO), medical-aware chunking (respecting section boundaries), embedding with domain-specific models (e.g., BGE-Med), vector store selection (Pinecone, Weaviate, Chroma), retrieval with MMR, prompt engineering with clinical guardrails, and source citation generation.

Cover dataset preparation (BIO tagging format), tokenization alignment with subword tokens, model selection (emilyalsentzer/Bio_ClinicalBERT), training with Trainer API, hyperparameter tuning, evaluation with entity-level F1 (exact match), and handling nested entities.

Cover AWS HealthLake or S3 + Glue for data ingestion, SageMaker for training (with spot instances), SageMaker Endpoints or Lambda for inference, CloudWatch for monitoring, Step Functions for orchestration, and IAM/KMS for HIPAA-compliant access control.

Cover concept set definition (choosing standard SNOMED/LOINC/RxNorm codes), cohort entry/exit criteria, inclusion/exclusion rules, characterization and cohort comparison, and exporting cohort definitions as JSON for programmatic use.

Cover experiment organization (by cohort/model type), logging parameters/metrics/artifacts, model registry with staging/production stages, reproducibility via conda/pip environment capture, and integration with healthcare-specific metrics (calibration, fairness).

Cover rule-based de-identification (regex for dates, MRNs) combined with NER-based approach (spaCy/scispaCy for PHI entities: names, locations, providers), regex post-processing, evaluation with i2b2 de-id metrics, and handling false negatives (leaked PHI) as the critical risk.

Cover global feature importance (summary plots), individual patient explanations (waterfall plots), translating feature names to clinical language, interactive exploration (force plots), and framing explanations in terms of actionable clinical factors.

Cover schema validation (Great Expectations), statistical distribution checks (drift detection on lab values, demographics), completeness metrics (missing data rates by source), anomaly detection, alerting thresholds, and data lineage tracking with dbt tests.

Cover sweep configuration for hyperparameter search, logging custom healthcare metrics (AUPRC, calibration slope, fairness metrics), parallel coordinate plots for hyperparameter analysis, model comparison tables, and artifact versioning for reproducibility.

Cover Spark Structured Streaming for real-time vital sign ingestion, FHIR subscription for ADT events, feature store for batch-computed features (comorbidities, medications), real-time model inference, and alert delivery via FHIR Communication resources or EHR inbox integration.

Strong answers demonstrate empathy for the clinician's time constraints, use of visualizations and clinical analogies, focus on actionable implications rather than methodology, and evidence of iterating on communication based on feedback.

Look for systematic investigation approach, transparent communication with stakeholders, documentation of the issue and resolution, and whether they considered the downstream impact on previous analyses.

Strong answers show respect for clinical expertise, evidence-based disagreement, willingness to adapt model design to clinical workflow, and focus on patient safety as the shared priority.

Look for structured learning habits (papers, conferences like AMIA/ML4H, OHDSI community), ability to evaluate new methods critically rather than hype-chasing, and a concrete example of applying new knowledge.

Strong answers demonstrate intellectual honesty, root cause analysis, learning from the failure (not just blaming data or stakeholders), and concrete changes to their process as a result.